Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall bextraA Bextra lawsuit can be filed by victims of the harmful side effects associated with taking this pain relieving prescription drug. Bextra is a COX-2 inhibiting non-steroidal anti-inflammatory drug (NSAID). This drug was introduced by Pfizer to the US drug market in November 2001 to treat the severe pain associated with osteoarthritis, rheumatoid arthritis and menstrual cramps.
Bextra, and other drugs of its class, have come under scrutiny for their potential to cause severe side effects ever since a similar drug, Vioxx, was pulled from the market in September 2004. Vioxx was pulled from the market after internal Pfizer clinical trials indicated that patients who take Vioxx have an increased chance of suffering a heart attack or stroke. Since the publication of these findings, the safety of drugs that are similar to Vioxx in form and function has come into question.
Vioxx and Bextra, along with similar drugs, act on the COX-2 enzyme to reduce tissue inflammation associated with severe pain. Original NSAID painkillers act on an additional enzyme, COX-1, which regulates the stomach lining. COX-1 inhibitors were left out of new NSAID formulations after ulcers and other gastrointestinal problems were association with COX-1 inhibition. Unfortunately, new scientific developments are revealing that some of these COX-2 selective NSAIDs double a patient''s risk of suffering heart problems and strokes.
A Bextra lawsuit is a civil action that can be brought against the manufacturers of this medication by patients who have suffered harmful side effects as a result of taking this prescription drug. Common side effects associated with Bextra include indigestion, headache, nausea, diarrhea, and abdominal pain. More severe side effects have also been associated with use of this medication.
Bextra has been proven to cause acute allergic reactions and skin diseases in some patients. In rare cases, taking Bextra causes fatal skin reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome. In light of this evidence, Pfizer has stated that they intend to add a black box warning to Bextra labeling, warning patients of these serious potential side effects.
In a preliminary study, presented at the American Heart Association meeting on November 9, 2004, it was revealed that Bextra may cause an increased risk of heart attack and stroke in patients. Pfizer claims that these findings are unsubstantiated and have not been legitimately documented. Both Pfizer and the FDA have stated that plans are underway to study the effects of Bextra and other COX-2 inhibitors on cardiovascular health.
If you have suffered harmful side effects as a result of taking Bextra, you may wish to contact an attorney who can determine your eligibility in a Bextra lawsuit. A Bextra lawsuit can help victims recover the damages they''ve suffered as a result of harmful Bextra side effects, including medical expenses, loss of income, and pain and suffering.
Bextra , the popular cox-2 inhibitor recalled by Pfizer, is the subject of another lawsuit.
Rita Fohne has filed her lawsuit against Pfizer in Madison County, Illinois, seeking ...
The U.S. Food and Drug Administration has started issuing alerts to patients and doctors on its new site Drug Watch. Including emerging drug-safety concerns, as well as dangers presented by drugs prescribed for unapproved uses, the new site is in resp...
After a controversial year of drug recalls, the FDA was under attack for failing to adequately protect consumers from dangerous drugs. Currently, the FDA has the Adverse Event Reporting System, or AERS, to collect voluntary reports of possible reactio...